The US Mission, which has 44 companies, will meet today with President Abdel Fattah Al Sisi. The mission will then resume its meeting with several ministers of the Economic Group, as well as a number of parliament members during their two-day visit to Egypt.
The mission includes companies from a variety of fields, such as energy and electricity, and there is a special presence, according to Tarek Tawfik, head of the American Chamber of Commerce in Cairo, by pharmaceutical companies, who expected in the coming period to expand their investments in the Egyptian market.
Tawfik attributed the American pharmaceutical companies’ intention to inject further investments soon, to reach a solution to numerous problems which previously impeded investments, such as the registration of new medicines, prices, and the registration period. This took place during the first companies’ meeting with the Minister of Health two years ago.
In this context, Tawfik explained that the three US companies have reached an agreement: Abbott Laboratories to test the hepatitis C virus, Pfizer to conduct field surveys, and Goliath for treatment protocols.
“There is no doubt that the economic reform process has given new credibility, compared to what is happening in other emerging markets of...